Introduction
Parkinson's disease (PD), the second most common neurodegenerative disorder in the United States, is characterized by tremors, bradykinesia, rigidity, and postural instability. The cellular hallmarks of the disease are loss of dopaminergic neurons originating in the substantia nigra (SN) and subsequent loss of dopamine in the striatum (Kish et al., 1988; Rinne, 1991) . Another important feature of PD is the presence of neuroinflammation. For example, some pro-inflammatory cytokines, such as interleukin (IL)-1β, tumor necrosis factor (TNF)-α, and others, can be found at higher levels in cerebrospinal fluid samples from PD patients compared to age-matched controls (Mogi et al., 1994a (Mogi et al., ,1994b (Mogi et al., , 1996 . Further supporting the involvement of inflammation, meta-analyses of several studies show that use of non-steroidal
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Abbreviations: aCSF, artificial cerebrospinal fluid; ANOVA, analysis of variance; BSA, bovine serum albumin; CX 3 CR1, CX 3 C-type chemokine receptor 1; GFP, enhanced green fluorescent protein; IL, interleukin; i.p, intraperitoneal; s.c, subcutaneous; LPS, lipopolysaccharide; MPTP, 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine; NSAIDs, non-steroidal anti-inflammatory drugs; PD, Parkinson's disease; PET, positron emission tomography; PFA, paraformaldehyde; RT-PCR, reverse transcriptase polymerase chain reaction; SN(c/r), substantia nigra (pars compacta/pars reticulata); TH, tyrosine hydroxylase; TNF, tumor necrosis factor; DAB, 3,3′-diaminobenzidine.
